GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 327 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $310,000 | -36.9% | 2,689 | -32.8% | 0.01% | -36.4% |
Q2 2020 | $491,000 | -74.3% | 4,000 | -78.1% | 0.01% | -15.4% |
Q4 2019 | $1,914,000 | -6.7% | 18,298 | +53.8% | 0.01% | -38.1% |
Q2 2019 | $2,051,000 | -4.2% | 11,900 | -6.3% | 0.02% | +10.5% |
Q1 2019 | $2,141,000 | – | 12,700 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital Management, LLC | 86,069 | $18,668,000 | 8.69% |
BARDIN HILL MANAGEMENT PARTNERS LP | 170,108 | $36,897,000 | 6.84% |
HARVEST MANAGEMENT LLC | 44,100 | $9,565,000 | 5.72% |
Twin Securities, Inc. | 39,541 | $8,576,000 | 5.50% |
TIG Advisors, LLC | 572,743 | $124,228,000 | 4.67% |
ALPINE ASSOCIATES MANAGEMENT INC. | 787,500 | $170,810,000 | 4.63% |
First Trust Capital Management L.P. | 105,822 | $22,953,000 | 4.49% |
Pentwater Capital Management LP | 2,102,104 | $455,946,000 | 4.35% |
OMNI PARTNERS LLP | 403,061 | $87,424,000 | 4.31% |
SPRING CREEK CAPITAL LLC | 370,000 | $80,253,000 | 3.47% |